Your browser doesn't support javascript.
loading
Development of a Platform for Producing Recombinant Protein Components of Epitope Vaccines for the Prevention of COVID-19.
Karyagina, Anna S; Gromov, Alexander V; Grunina, Tatyana M; Lyaschuk, Alexander M; Grishin, Alexander V; Strukova, Natalia V; Generalova, Maria S; Galushkina, Zoya M; Soboleva, Lyubov' A; Dobrinina, Olga Yu; Bolshakova, Tatyana N; Subbotina, Marina E; Romanovskaya-Romanko, Ekaterina A; Krasilnikov, Igor V; Polyakov, Nikita B; Solovyev, Andrey I; Grumov, Daniil A; Zhukhovitsky, Vladimir G; Ryabova, Ekaterina I; Prokofiev, Vladimir V; Lunin, Vladimir G.
Afiliación
  • Karyagina AS; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. akaryagina@gmail.com.
  • Gromov AV; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.
  • Grunina TM; Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119992, Russia.
  • Lyaschuk AM; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Grishin AV; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Strukova NV; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.
  • Generalova MS; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Galushkina ZM; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Soboleva LA; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Dobrinina OY; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Bolshakova TN; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Subbotina ME; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Romanovskaya-Romanko EA; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Krasilnikov IV; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Polyakov NB; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia. subbotinam@gmail.com.
  • Solovyev AI; All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia.
  • Grumov DA; Institute of Influenza, Ministry of Health of the Russian Federation, St. Petersburg, 197376, Russia.
  • Zhukhovitsky VG; Saint Petersburg Institute of Vaccines and Sera, FMBA, St. Petersburg, 198320, Russia.
  • Ryabova EI; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
  • Prokofiev VV; Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Moscow, 119991, Russia.
  • Lunin VG; Gamaleya National Research Center of Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia.
Biochemistry (Mosc) ; 86(10): 1275-1287, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34903153

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Epítopos Límite: Animals / Female / Humans Idioma: En Revista: Biochemistry (Mosc) Año: 2021 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Epítopos Límite: Animals / Female / Humans Idioma: En Revista: Biochemistry (Mosc) Año: 2021 Tipo del documento: Article País de afiliación: Rusia Pais de publicación: Estados Unidos